Management of acute promyelocytic leukemia relapse in the ATRA era

Haematologica

Volumn 83, Issue 8, 1998, Pages 714-717

  Castagnola, Carlo ^a,b   Lunghi, Monia ^a   Corso, Alessandro ^a   Tajana, Monica ^a   Zappasodi, Patrizia ^a   Dabusti, Melissa ^a   Lazzarino, Mario ^a   Bernasconi, Carlo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Acute myeloid leukemia; Acute promyelocytic leukemia; ATRA; Relapse; Second remission

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; IDARUBICIN; MITOXANTRONE; RETINOIC ACID; TIOGUANINE;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL PROTOCOL; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FEMALE; HUMANS; IDARUBICIN; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MITOXANTRONE; RECURRENCE; REMISSION INDUCTION; SALVAGE THERAPY; THIOGUANINE; TREATMENT OUTCOME; TRETINOIN;

EID: 0031755276     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Warrell RP Jr, de The' H, Wang Z-Y, et al. Acute promyelocytic leukemia. N Engl J Med 1993; 329:177-89.
2. Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72:567-76.
3. Fenaux P, Chomienne C, Degos L. Acute promyelocytic leukemia: biology and treatment. Semin Oncol 1997; 24:92-102.
4. Third International Workshop on chromosome in leukemia. Cancer Genet Cytogenet 1980; 4:95-142.
5. Davis CL, Rohatiner ZS, Lim J, et al. The management of recurrent acute myelogenous leukemia at a single centre over a fifteen-year period. Br J Haematol 1993; 83:404-11.
6. Castagnola C, Nozza A, Bonfichi M, et al. Leucemia mieloide acuta in ricaduta: analisi di 70 pazienti [abstract]. 35° Congresso nazionale Società Italiana di Ematologia 1995; p. 170.
7. Ohno R, Ohnishi K, Takeshita A, et al. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan. Leukemia 1994; 8(Suppl.3):S64-S69.
8. Tallman MS, Andersen JW, Schiffer CA, et al. All-trans retinoic acid in acute promyelocytic leukemia. N Engl J Med 1977; 337:1021-8.
9. Mandelli F, Diverio D, Avvisati G, et al. Molecular Remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and Idarubicin (AIDA) protocol. Blood 1977; 90:1014-21.
10. nd International Symposium on Acute promyelocytic leukemia a curable disease, 1997, p. 15.
11. Frankel SR, Eardley A, Heller G, et al. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study. Ann Intern Med 1994; 120:278-86.
12. Korninger L, Knobl P, Laczika K, et al. PML-RARα positivity PCR in the bone marrow of patients with APL precedes haematological relapse by 2-3 months. Br J Haematol 1994; 88:427-31.
13. Diverio D, Riccioni R, Mandelli F, et al. The PML-RARα fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia. Haematologica 1995; 80: 155-60.